DOH request its NCR hospitals to facilitate patient recruitment for clinical trial.

The Department of Health through its memorandum addressed to all chiefs of medical centers and hospitals in NCR encourages the participation of all concerned in facilitating the recruitment of patients that are eligible for the trial and in referring them to the study sites for screening.

The participants will be under the trial which aims to determine and compare the safety and effect of additional three (3) study drugs (i.e., Artesunate IV, Imatinib Oral, and Infliximab IV) with Standard of Care for COVID-19 management versus Standard of Care alone which is led by Dr. Marissa Alejandria.

The list of study sites as well as the contact details of the focal persons can be accessed in the document below.